Bird & Bird advised Health-Tech-VC on EUR 1.3 million investment in RYVER.AI

Contacts

andrea schlote Module
Andrea Schlote

Counsel
Germany

As a Counsel in our Corporate / M&A Team in Munich, I focus on domestic and international venture capital and venture lending transactions for emerging and high-growth companies.

The international law firm Bird & Bird has advised the Spanish health-tech venture capital firm, Nina Capital, on its investment in the Munich-based health-tech startup, RYVER.AI.

Nina Capital led the financing round, other investors include Bayern Kapital (Germany) and FundF (Austria). The capital will primarily be used for technical development, personnel and computing capacity. RYVER.AI develops generative models that enable medical AI providers to generate a wide range of test and training data quickly and cost-effectively. The start-up aims to solve the data shortage for medical AI without jeopardizing patient privacy. The company develops generative AI to create artificial but highly realistic datasets of radiological images.

Nina Capital was advised by the following Bird & Bird lawyers: counsel Andrea Schlote (lead), Partner Stefan Münch, counsel Dr. Christina Lorenz, associate Louisa Graf (all Corporate/M&A, Munich), Partner Martin von Haller Grønbæk (Commercial, Copenhagen) and associate Yvonne Schaafs (IP, Munich).


News & Deals

More News & Deals
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More